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Abstract
OBJECTIVE: To evaluate the self-efficacy and satis-
faction of asthma patients subjected to summer
acupoint application treatment (SAAT).
METHODS: A two-year follow-up clinical study was
conducted. Patients with asthma were treated by
applying a herbal paste onto the Feishu (BL 13) and
Fengmen (BL 12) acupoints on the three hottest
days of summer, according to the traditional Chi-
nese calendar, from 2008 to 2010. During a
two-year follow-up, these patients were asked to
fill out a questionnaire evaluating asthma degree,
exacerbation frequency, concomitant medications
and self-satisfaction. The self-rate and doctor-re-
port outcomes obtained in parallel were evaluated
to assess the efficacy of SAAT.
RESULTS: A total of 527 asthma patients were ini-
tially enrolled in this study, of which 97 elderly pa-
tients and those with more severe cases of asthma
were lost to follow-up. Thus, a total of 430 patients
were valid for analysis using self-rate data. Never-
theless, occasional negative returns were obtained;
almost all of the outcomes were rated as "No
change", "Moderate effective", or "Very effective". In
addition, 80% of the patients were satisfied with
this treatment. Moreover, 391 (91.4% ) patients
were somewhat improved after SAAT in 2009, and
further improvement was observed in 2010. After
SAAT, the average asthma-degree score decreased
from 5.3 in 2008 to 4 in 2009 and, subsequently to
3.5 in 2010.
CONCLUSION: With pronounced patient satisfac-
tion, SAAT can reduce the exacerbation severity
and frequency, concomitant medications and asth-
ma degree. Prolonging the treatment course might
enhance the efficacy of SAAT.
© 2015 JTCM. All rights reserved.
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INTRODUCTION
Asthma is one of the most prevalent diseases, affecting
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as many as 300 million people and accounting for ap-
proximately 250 000 annual deaths worldwide.1 De-
spite improvements in the quality of care, there is no
overall global downward trend in the prevalence of
asthma.2 The number of asthmatic patients was estimat-
ed to increase by 100 million individuals by 2025.1 In
the United States, the prevalence of asthma was 8.5%
of the population in 2012,3 and both the period preva-
lence and the current prevalence of asthma have consis-
tently increased during the last decade.4 The prevalence
of asthma in China is much lower than that in Western
countries and varies between different regions in the
country.5 In large cities, the asthma prevalence is 11
percent and rising.6 A literature survey indicated that
the current average prevalence of asthma for children
in China had increased from 0.9% in 1990 to 1.5% in
2000.7 It was also estimated that the rates of asthma
prevalence have increased as much as 40 percent over
the last five years in China.6
Asthma affects the lives of patients and their families,
including their quality of life, productivity at work and
school, and health care use, and this disease can even
result in death. An estimated 15 million disability-ad-
justed life years have been lost per year worldwide due
to asthma.1 Treating patients with severe asthma would
be a heavy burden on healthcare resources and econom-
ics. For instance, the financial burden on patients with
asthma in different Western countries ranges from
$300 to $1300 per patient per year.8 In 2007, in the
United States, the total incremental cost of asthma to
society was $56 billion, where the productivity losses
due to morbidity and mortality accounted for $3.8 and
$2.1 billion, respectively.9 Prescription drugs have typi-
cally been used to treat chronic pulmonary disease, po-
tentially creating heavy economic burden for asthmatic
patients. This burden is particularly heavy in develop-
ing countries due to limited health care. Complementa-
ry treatment methods have emerged due to their lower
cost and lighter side effects. Several complementary
treatment methods have been developed, such as acu-
puncture, moxibustion (direct and indirect), herbal
remedies, inspiratory muscle training, and massage and
chiropractic therapy. In China, acupuncture and moxi-
bustion are the common treatment methods. Summer
acupoint application treatment (SAAT), also known as
Sanfujiu10 is one type of direct moxibustion adminis-
tered in the summer through the direct application of
an irritating herbal paste to acupuncture points.11 Un-
like normal direct moxibustion, SAAT substitutes the
use of moxa with herbal paste during disease treat-
ment. Several clinical studies have shown a favorable
effect of SAAT for asthma.12 Due to the cheap price
and fast and convenient application, SAAT has been ex-
tensively used in Chinese hospitals and clinics. More
importantly, there is almost no risk of burns for pa-
tients with SAAT compared with other moxibustion
treatments.
Despite the extensive use of SAAT on asthmatic pa-
tients in China, the therapeutic effects of SAAT re-
mains insufficiently understood. Thus, we conducted a
clinical observation study with a two-year follow-up.
MATERIALS ANDMETHODS
Study population
We conducted a two-year follow-up study based on pa-
tients from 3 clinical centers in China. They were
Guang'anmen Hospital, China Academy of Chinese
Medical Science (Beijing), The First Hospital of Hu-
nan University of Chinese Medicine (Changsha, Hu-
nan), The Second Hospital of Anhui University of Chi-
nese Medicine (Hefei, Anhui). Patients diagnosed with
asthma according to previously established guidelines13
were consecutively recruited during July 19th to Au-
gust 18th in 2008. We excluded patients (a) aged < 2
years; (b) during pregnancy or lactation; (c) with aller-
gies to the herb or accessories; (d) temperature ≥ 37.5
Celsius degree; (e) producing yellow and thick sputum;
(f ) exhibiting bronchiectasis, endobronchial tuberculo-
sis, lung cancer, pulmonary fibrosis, and uncontrolled
diabetes; or (g) previously diagnosed with severe heart,
liver or kidney disease, mental disease, or cancer. A
complete description of the patient selection criteria
has been reported elsewhere.14 This study protocol
(Registration No. ChiCTR-OCH-10001292), for all
clinical centers, was approved through the Ethics Com-
mittees of the Institution of Basic Research in Clinical
Medicine, China Academy of Chinese Medicine. Writ-
ten informed consent was provided by each study par-
ticipants or his/her guardian.
Treatment method
The patients were treated with SAAT at each clinic.
The herbal pastes comprised approximately 35% Se-
men Baijiezi (Semen Sinapis), 10% Gansui (Radix Kan-
sui), 25% Xixin (Herba Asari Mandshurici), and 30%
Yanhusuo (Rhizoma Corydalis Yanhusuo). These herbs
were ground into a powder, mixed and made into paste
using old ginger juice. The resulting paste was cut into
small cubes of 1 cm × 1 cm in size and glued onto a
medical tap for SAAT. For clinical treatment, the medi-
cal taps with herbal pastes were placed onto the select-
ed acupuncture points, remaining at least 2 h. The
standard acupoints included Feishu (BL 13) and Feng-
men (BL 12), — the meridians named Taiyang Blad-
der Meridian of Foot.
Both Feishu (BL 13) and Fengmen (BL 12) are impor-
tant acupoints in the pathway of the lung meridian.
The appealing associations between Feishu (BL 13)
and/or Fengmen (BL 12) with asthma have been previ-
ously reported.15,16 The treatments were conducted
from July 19th to August 18th (3 times, 10 days per
time), the hottest days in summer, according to the lu-
nar calendar, in 2008, 2009 and 2010.
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Data collection
The patients were enrolled and initially treated at the
screening centers by well-trained doctors during the Ju-
ly 19th to August 18th in 2008. The information col-
lected before treatment included age, gender, disease
and treatment (SAAT) history. In subsequent (2009
and 2010), all patients were invited for return visits to
receive continued treatment. An assessment of the effi-
cacy of the last period treatment was obtained using
synthetic indicators. Because neither active nor sham
acupuncture treatments significantly affected pulmo-
nary function, according to Choi et al 17 using pulmo-
nary function as a primary outcome would be inappro-
priate in clinical investigation. Instead, doctor-report
outcomes were used in this study. At the return visits,
the patients completed a questionnaire, assessing exac-
erbation severity and frequency, concomitant medica-
tions and self-satisfaction. After each treatment period,
the outcomes were rated in five categories: "much
worse", "worse", "no change", "moderate effective",
and "very effective". The asthma degree was assessed us-
ing a visual analog scale, from 0 (mildest) to 10 (sever-
est).18 The treatment procedure, follow-up and data col-
lection are schematically illustrated in Figure 1.
Data analysis
Descriptive statistics were generated to examine the de-
mographic and disease characteristics of the patients.
Figures showing the changes in the severity, exacerba-
tion frequency, concomitant medications and self-satis-
faction were constructed. Differences between groups
were tested using the t test or Chi-squared test, depend-
ing on the nature of the variables. P < 0.05 was consid-
ered statistically significant. The data were analyzed us-
ing the "epicalc" package of software R, version 2.12.1
(R Core Team, Vienna, Austria).
RESULTS
General description
A total of 527 asthma patients were initially enrolled in
this study, of which 97 patients were lost to follow up.
Thus, the 430 remaining patients were valid for analy-
sis. Table 1 shows the demographic and clinical charac-
teristics of the patients who completed the study and
those patients who were lost to follow up. No signifi-
cant differences were observed between sex, and disease
and SAAT history in these two groups. In addition, the
patients lost to follow up were older, with a lesser de-
gree, severity and frequency of exacerbations than pa-
tients included in this study. A total of 245 (57.0% )
study participants were female, with a mean [standard
deviation (SD)] age of 43 (23) years. The participants
exhibited a moderate disease condition at baseline,
with a mean (SD) degree score of 5 (2). 246 (57.6%)
patients were diagnosed with moderate severity of asth-
ma, and 283 (66.9% ) individuals reported less than
one exacerbation per month, with a mean (SD) disease
history of 11 (11) years. A total of 174 (48.2% ) pa-
tients had received SAAT before this study.
Efficacy evaluation
Except for some individual negative returns, almost all
Figure 1 Procedure diagram of this study
SAAT: summer acupoint application treatment.
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of the outcomes were rated as "No change", "Moderate
effective", "Very effective". These results suggest that
the symptoms of asthma relief after SAAT, i.e., the se-
verity and frequency of exacerbations, were reduced,
and the concomitant medications were substantially re-
duced (Figure 2A-2C). In addition, 80% of the pa-
tients were more or less satisfied with this treatment
(Figure 2D).
Moreover, 391 (91.4% ) patients were somehow im-
proved after SAAT in 2009, and further improvement
(93% ) was observed in 2010 according to the doc-
tor-report outcome (Table 2). This result suggests that
the efficacy of this treatment is enhanced with pro-
longed treatment time.
After SAAT, the average value for the asthma degree
scores was substantially reduced from 5.2 ± 2.0 in
2008 to 4.0 ± 1.6 in 2009, and subsequently to 3.5 ± 1.3
in 2010. This result confirms the therapeutic efficacy
of SAAT on asthma and the benefit of enduring treat-
ment.
DISCUSSION
Asthma is a chronic respiratory disease characterized by
episodes or attacks of impaired breathing. The inflam-
mation and narrowing of small airways can cause short-
ness of breath, coughing, wheezing, chest pain, etc.
Large efforts have been made to control and prevent
the development of asthma. The well-established treat-
ment of asthma includes the use of medication for
short-term relief to decrease inflammation and avert at-
tack and the daily use of preventive medication to con-
trol inflammation and airway hyperreactivity. In addi-
tion, doctors typically recommend the establishment of
sufficient health care measures, such as monitoring early
symptoms, avoiding factors that trigger attacks, and re-
moving risks. However, concomitant medications for
morbidity and direct/indirect health care costs due to
asthma continue to pose a high burden for patients
and their families. The use of complementary and alter-
native treatment could provide an option to control
the symptoms of asthma and lower the economic bur-
den of health care and therapy. As a typical and conven-
tional treatment method for pulmonary disease, SAAT
has demonstrated promising effects.17-26 Most clinical re-
ports have suggested that SAAT substantially improves
the life quality of patients. Yet the mechanisms of
SAAT for the treatment of asthma remain elusive.
The action of hydrogel herbal paste used in SAAT on
acupoint meridian can be triggered through the perme-
ation of active medicines through the skin.27 According
to the Traditional Chinese Medicine theory, people
with an imbalanced flow of energy (so called "Qi")
along the meridians will suffer chronic pulmonary dis-
eases, and the herbal paste in SAAT could regulate the
flow of "Qi".28,29 The stimulation of a function-specific
point [Fengmen (BL 12) and Feishu (BL 13)] for an or-
gan might affect the meridian (lung meridian) associat-
ed with that organ through an enhancement of the
flow of Qi. With functions to dredge and activate the
lung meridian, the stimulation of Fengmen (BL 12)
could regulate the flow of the meridian "Qi".16 The the-
ory of energy flow within the meridian system has
been explained in Western Medicine by the semicon-
ducting properties of the skeletal and connective tissue
systems.30 Carneitro et al 31 demonstrated the effect of
asthma therapy on asthmatic rats through the stimula-
tion of the acupoint Feishu (BL 13), showing that both
lung inflammation and cellular inflammatory in the
bronchoalveolar lavage was significantly reduced
through acupoint stimulation. Ngai et al 32 applied
transcutaneous electrical nervous stimulation over Fei-
Characteristic
Sex (female) [n (%)]
Mean (SD) age (years)
Mean (SD) degree (scores)
Severity of asthma [n (%)]
Frequency of exacerbations [n (%)]
Mild
Moderate
Heavy
Mean (SD) disease history (years)
≤ 1 time/m
2-3 times/m
1-2 times/w
≥ 3 times/w
SAAT history [n (%)]
Completed fllow up (n = 430)
245 (57.0)
43 (23)
5 (2)
141 (33.0)
246 (57.6)
40 (9.4)
11 (11.1)
283 (66.9)
75 (17.7)
37 (8.7)
28 (6.6)
174 (48.2)
Lost to follow up (n = 97)
59 (61.5)
48 (19)
4 (2)
54 (55.7)
40 (41.2)
3 (3.1)
12 (11.6)
76 (80.0)
16 (16.8)
1 (1.1)
2 (2.1)
39 (47.6)
P valuea
0.579
0.019
< 0.001
< 0.001
-
-
0.281
0.006
-
-
-
1.000
Table 1 Baseline characteristics of the patients
Notes: SD: standard deviation; m: month; w: week; SAAT: summer acupoint application treatment. aDifferences between two groups were
tested using the χ2 or t tests according to the nature of the variables.
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shu (BL 13) and showed that this stimulation modifies
the skin impedance of acupoints along a related meridi-
an and likely modulates sympathovagal balance, as the
stimulation of these points might impact nerve endings
via ionic or electrical changes. In addition, stimulating
meridian acupoints indicating nerve responses have al-
so been directly evidenced through functional magnet-
ic resonance imaging.33 Ultrasonic imaging supports an
association between acupoints, muscular connective tis-
sue,34 collagenous bands35 and blood flow.36 A study us-
ing laser Doppler flowmetry also demonstrated the
strengthening of blood flow after acupoint stimulation,
likely reflecting the activated circulation of tissue fluid
inside the meridian.37 In the neural hypothesis, the clin-
ical influence of acupoint stimulation provides signals
to the brain through sensory nerves, causing clinical
changes associated with treatment.38
From the point view of immunomodulation, acupoint
stimulation might improve immunity. Numerous stud-
ies of general immune parameters (IgA, IgM, IgG and
IgE, etc.) have shown a statistically significant enhance-
ment of immunity through SAAT.21 Significant chang-
es in cytokine concentrations (e.g., IL-6 and IL-10,
IL-8) under acupoint stimulation were also observed.39
Drugs used for asthma treatment, such as steroids and
b2-agonists, shift the balance of Th1/Th2 towards
Th1.40 The effect of restoring balance to the Th1/Th2
responses through acupoint stimulation has also been
extensively reported.41,42
However, numerous have suggested that the effects of re-
al and/or sham acupoint treatment on pulmonary func-
tion in asthmatic patients remain insignificant.17,23,24
Randomized controlled trials (RCTs) on asthmatic pa-
tients using acu-TENs have also confirmed that there
are no obvious effects on the improvement of pulmo-
nary function,25 while some clinical studies have report-
ed the positive effect of acupoint treatment on pulmo-
nary function in asthmatic patients.22,43 Literature sur-
veying suggests that the treatment of stimulating acu-
points, using needles, paste or acu-Tens, is a placebo.
However, clinical observations from a large amount of
patients in different hospitals in China have shown
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Parameter
Very effective
Moderate effective
No change
Worse
Total
Very effective
91 (21.2)
22 (5.1)
2 (0.5)
0 (0.0)
115 (26.8)
Moderate effective
29 (6.7)
235 (54.7)
14 (3.3)
0 (0.0)
278 (64.8)
No change
3 (0.7)
16 (3.7)
15 (3.5)
0 (0.0)
34 (7.9)
Worse
0 (0.0)
3 (0.7)
0 (0.0)
0 (0.0)
3 (0.7)
Total
123 (28.6)
276 (64.2)
31 (7.2)
0 (0.0)
430 (100.0)
Table 2 Crosstab of doctor report outcome in 2009 (Horizontal) and 2010 (Vertical) [n (%)]
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that SAAT can certainly and remarkably improve the
quality of life of patients.18,19,21 Moreover, the apparent
efficacy of SAAT on patients with asthma is substantial-
ly high (> 80%, Table 3). Moreover, Chen et al 44 con-
ducted a comparative study, showing that therapeutic
effect of SAAT is superior to that of routine needle acu-
puncture (SAAT vs needle acupuncture: 94% vs 76%).
More rigorous studies (i.e., RCTs, long time follow-up,
pulmonary function tests) are needed to further under-
stand the mechanisms and the factors that influence
the therapeutic efficacy of SAAT.
Herein, we presented a two-year follow-up study to in-
vestigate the therapeutic effects of SAAT in 430 valid
patients in China. Younger patients and those with
more severe symptoms are more likely to complete a
two-year or more treatment course. Based on self-rate
and doctor-report outcomes, SAAT can reduce the se-
verity and frequency of asthma exacerbations and con-
comitant medications with plausible satisfaction. The
efficacy of this treatment is enhanced with a prolonged
treatment course.
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